Report overview
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Anti-infective Preparations, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Anti-infective Preparations. This report contains market size and forecasts of Ophthalmic Anti-infective Preparations in global, including the following market information:
Global Ophthalmic Anti-infective Preparations Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ophthalmic Anti-infective Preparations Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Ophthalmic Anti-infective Preparations companies in 2022 (%)
The global Ophthalmic Anti-infective Preparations market was valued at US$ 1510.6 million in 2022 and is projected to reach US$ 1877.9 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
We surveyed the Ophthalmic Anti-infective Preparations manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Anti-infective Preparations Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Ophthalmic Anti-infective Preparations Market Segment Percentages, by Type, 2022 (%)
Antibacterial
Antiviral
Antifungal
Anti-parasitic
Others
Global Ophthalmic Anti-infective Preparations Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Ophthalmic Anti-infective Preparations Market Segment Percentages, by Application, 2022 (%)
Hospital Use
Clinic Use
Household
Other
Global Ophthalmic Anti-infective Preparations Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Ophthalmic Anti-infective Preparations Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Anti-infective Preparations revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ophthalmic Anti-infective Preparations revenues share in global market, 2022 (%)
Key companies Ophthalmic Anti-infective Preparations sales in global market, 2018-2023 (Estimated), (MT)
Key companies Ophthalmic Anti-infective Preparations sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan PLC
Bayer AG
F. Hoffmann-La Roche AG
Johnson and Johnson Vision Care Inc
Kyowa Kirin Co., Ltd
Novartis International AG
Pfizer, Inc.
Regeneron Pharmaceuticals, Inc.
Santen Pharmaceuticals Co., Ltd.
Shire PLC
Bausch Health
Lupin Pharmaceuticals
Apotex
Akorn
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Anti-infective Preparations, market overview.
Chapter 2: Global Ophthalmic Anti-infective Preparations market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmic Anti-infective Preparations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Anti-infective Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmic Anti-infective Preparations capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
